Press Releases

Company press releases and official corporate announcements.

A centralized feed of corporate press releases, earnings announcements, mergers, and official statements. Content is presented for informational purposes and may require additional analysis for market relevance.

Articles

18,760 total articles

Rocket Lab Corporation Announces Progress on Iridium Acquisition: HSR Period Lapses; Form S-4 Filed; FCC Applications Filed; Capital Strategy Underway

Rocket Lab Corporation Announces Progress on Iridium Acquisition: HSR Period Lapses; Form S-4 Filed; FCC Applications Filed; Capital Strategy Underway

Rocket Lab Corporation has reached important milestones in its planned acquisition of Iridium Communications, including the lapse of the Hart-Scott-Rodino antitrust waiting period, filing a Form S-4 registration statement with the SEC, and submitting FCC applications to transfer control of Iridium's licenses. The company is advancing its capital st…

Pyxis Oncology Reports Second Quarter 2026 Financial Results and Advances MICVO Toward Key 2026 Clinical Milestones

Pyxis Oncology Reports Second Quarter 2026 Financial Results and Advances MICVO Toward Key 2026 Clinical Milestones

Pyxis Oncology reported its Q2 2026 financial results and highlighted progress in its MICVO clinical programs targeting recurrent/metastatic head and neck squamous cell carcinoma (R/M HNSCC). The company completed a private placement raising approximately $50 million upfront, extending its cash runway into Q2 2027. Updated data from Phase 1 monothe…

FactSet Declares Dividend

FactSet Declares Dividend

FactSet has announced a quarterly cash dividend of $1.16 per share, payable on September 17, 2026, to shareholders of record as of August 31, 2026. The company continues to demonstrate commitment to delivering value to shareholders amid its ongoing provision of financial intelligence and AI solutions globally.

Olema Oncology Appoints Jason O’Byrne as Chief Financial Officer

Olema Oncology Appoints Jason O’Byrne as Chief Financial Officer

Olema Pharmaceuticals, a clinical-stage biopharmaceutical company focused on breast cancer therapies, announced the appointment of Jason O’Byrne as Chief Financial Officer. With a strong background in biotech finance and operations, O’Byrne will support Olema as it approaches key clinical data readouts and prepares for its initial commercial launch…

Nutriband CEO, Gareth Sheridan to Present at the 2026 Georgia Life Sciences Summit as Part of the CEO Spotlight

Nutriband CEO, Gareth Sheridan to Present at the 2026 Georgia Life Sciences Summit as Part of the CEO Spotlight

Nutriband Inc.'s CEO Gareth Sheridan will present at the 2026 Georgia Life Sciences Summit focusing on the company's AVERSA™ abuse-deterrent transdermal technology designed to prevent abuse and accidental exposure of drugs like fentanyl. The technology is covered by broad international patents and aims to improve safety profiles of transdermal drug…

Aebi Schmidt Group Reports 22% Increase in Adjusted EBITDA, 16% Growth in Order Intake and 9% Increase in Net Sales, Reflecting Strong Order Momentum and Over-Proportional Profitability Improvement

Aebi Schmidt Group Reports 22% Increase in Adjusted EBITDA, 16% Growth in Order Intake and 9% Increase in Net Sales, Reflecting Strong Order Momentum and Over-Proportional Profitability Improvement

Aebi Schmidt Group reported a 22% increase in adjusted EBITDA and a 16% growth in order intake for Q2 2026 compared to Q2 2025, alongside a 9% rise in net sales. The company attributes its improved profitability to operational improvements and an expanded market footprint, with strong performance in North America and Europe. Net income turned posit…

ProQR Announces Second Quarter 2026 Operating and Financial Results

ProQR Announces Second Quarter 2026 Operating and Financial Results

ProQR Therapeutics reported positive Phase 1 target engagement data for AX-0810, marking the first clinical validation of its proprietary Axiomer RNA editing platform targeting NTCP modulation for cholestatic diseases. The company outlined a robust pipeline with upcoming clinical milestones including Phase 1 data for AX-0811, initiation of biliary …

Legence Reports Second Quarter 2026 Financial Results

Legence Reports Second Quarter 2026 Financial Results

Legence Corp. reported strong second quarter 2026 financial results with record revenues of $1.26 billion, a 111% increase year-over-year, driven by solid organic growth and the Bowers acquisition. Adjusted EBITDA more than doubled to $154.6 million. The company also reported record backlog and awarded contracts totaling $5.67 billion, a 105% incre…

Parabilis Medicines Reports Second Quarter 2026 Financial Results and Provides Business Updates

Parabilis Medicines Reports Second Quarter 2026 Financial Results and Provides Business Updates

Parabilis Medicines reported progress in its clinical programs, especially zolucatetide—an investigational direct inhibitor targeting the β-catenin:TCF interaction in multiple Wnt/β-catenin-driven diseases. The company plans to initiate a Phase 3 registrational trial for desmoid tumors in early 2027. Parabilis also announced a major collaboration w…

Brookfield Wealth Solutions Announces Strong Second Quarter Results

Brookfield Wealth Solutions Announces Strong Second Quarter Results

Brookfield Wealth Solutions announced strong second quarter 2026 results, highlighted by a significant increase in total assets surpassing $200 billion, driven by the successful acquisition and integration of Just Group plc. The company reported distributable operating earnings growth and expanded international operations, with substantial annuity …

Bending Spoons announces Q2 2026 results

Bending Spoons announces Q2 2026 results

Bending Spoons announced Q2 2026 financial results showing a 126% increase in revenue to $704 million and a 139% rise in operating income to $240 million compared to Q2 2025. Diluted EPS increased 163% to $0.28. The company completed an IPO on Nasdaq under symbol BSP, raising $1.10 billion. It acquired Tractive and entered an agreement to acquire A…

Dillard’s, Inc. Reports Second Quarter and Year-to-Date Results

Dillard’s, Inc. Reports Second Quarter and Year-to-Date Results

Dillard's, Inc. announced a 1% increase in total retail sales and a significant rise in net income to $97.7 million for Q2 2026 compared to the prior year. The company's retail gross margin improved due to tariff refunds and a favorable litigation settlement related to payment card interchange fees. Operating expenses rose slightly due to higher pa…

Titan Machinery Inc. to Report Fiscal Second Quarter Ended July 31, 2026 Results on Thursday, August 27, 2026

Titan Machinery Inc. to Report Fiscal Second Quarter Ended July 31, 2026 Results on Thursday, August 27, 2026

Titan Machinery Inc. plans to release its financial results for the fiscal second quarter ended July 31, 2026, on August 27, 2026, followed by a live investor conference call. The company operates a large network of agricultural and construction equipment dealerships across North America, Europe, and Australia, representing CNH Industrial Brands.